J Cancer 2018; 9(11):2046-2053. doi:10.7150/jca.24474 This issue Cite

Research Paper

A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer

Jasmine Evert1#, Surajit Pathak2,3#, Xiao-Feng Sun2, Hong Zhang1✉

1. School of Medical Sciences, Örebro University, SE 70182 Örebro, Sweden.
2. Department of Oncology and Department of Clinical and Experimental Medicine, SE-581 83, Linköping University, Linköping, Sweden.
3. Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Kelambakkam, India, 603 103.
# Contributed equally to the work.

Citation:
Evert J, Pathak S, Sun XF, Zhang H. A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. J Cancer 2018; 9(11):2046-2053. doi:10.7150/jca.24474. https://www.jcancer.org/v09p2046.htm
Other styles

File import instruction

Abstract

Colorectal cancer is a commonly diagnosed malignancy and also the major cause of death worldwide. Chemotherapy is the primary therapy for advanced colorectal cancer. Although oxaliplatin has potential effect in colorectal cancer therapy, the molecular mechanisms involved in its cytotoxic effects are not well elucidated. This study outlines the regulatory effects of oxaliplatin on miRNAs expression in colon cancer cells and correlates it with the changing microRNA expression with p53 and p73 expression status in cells. HCT116p53+/+ and HCT116p53-/- cells were exposed to oxaliplatin, and the cellular viability was determined by XTT. p73 was knocked down using siRNA and the tumor cells were then treated with oxaliplatin. The expression profile of 384 miRNAs was determined by TaqMan® human miRNA array and calculated by the ∆∆Ct method. Cellular viability was found to decrease after the treatment with oxaliplatin in a dose-dependent manner. The wild-type p53 cells were found to be more sensitive than the null-p53 derivatives. A selective set of miRNAs were either up-regulated or down-regulated in response to the oxaliplatin treatment with a presumable role of p53 and p73 proteins. The miRNAs expression is known to influence the pharmacodynamic mechanisms of oxaliplatin and these effects have been observed to be regulated by p53 and p73. Our results may therefore provide more evidence for identifying a suitable biomarker for the diagnosis of colon cancer.

Keywords: Oxaliplatin, miRNAs, p53, p73, colon cancer cells.


Citation styles

APA
Evert, J., Pathak, S., Sun, X.F., Zhang, H. (2018). A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. Journal of Cancer, 9(11), 2046-2053. https://doi.org/10.7150/jca.24474.

ACS
Evert, J.; Pathak, S.; Sun, X.F.; Zhang, H. A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. J. Cancer 2018, 9 (11), 2046-2053. DOI: 10.7150/jca.24474.

NLM
Evert J, Pathak S, Sun XF, Zhang H. A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. J Cancer 2018; 9(11):2046-2053. doi:10.7150/jca.24474. https://www.jcancer.org/v09p2046.htm

CSE
Evert J, Pathak S, Sun XF, Zhang H. 2018. A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. J Cancer. 9(11):2046-2053.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image